Evidence that heparin but not hirudin reduces PAI-1 expression in cultured human endothelial cells

Thromb Res. 1999 May 1;94(3):137-45. doi: 10.1016/s0049-3848(98)00203-5.

Abstract

Heparin and other antithrombotic drugs besides their anticoagulant action could have a profibrinolytic effect. We have analyzed the effect of unfractionated heparin (UFH) and hirudin on PAI-1 gene expression in human umbilical vein endothelial cells (HUVEC). Cells were stimulated with UFH (1 and 10 IU/ml) and hirudin (20 and 100 TIU/ml). Samples were obtained before and 2, 6, and 24 hours after stimulation. mRNA analysis was conducted by reverse transcription followed by polymerase chain reaction, and PAI-1 antigen was determined by ELISA. Addition of UFH (10 IU/ml) to HUVEC resulted in a decrease of PAI-1 mRNA at 6 hours (40% reduction) and 24 hours (60% reduction) and PAI-1 antigen. Hirudin, however, did not modify significantly the PAI-1 mRNA nor the inhibitor secretion. The addition of UFH (10 or 100 IU/ml) to endotoxin-stimulated HUVEC also reduced the increased PAI-1 mRNA and antigen secretion (45%), whereas no effect could be observed with hirudin. Our results suggest that UFH, but not hirudin, by reducing the endothelial expression of PAI-1 might have a profibrinolytic effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / metabolism*
  • Endotoxins / pharmacology
  • Fetal Blood / cytology
  • Fibrinolytic Agents / pharmacology
  • Gene Amplification
  • Gene Expression / drug effects
  • Glyceraldehyde-3-Phosphate Dehydrogenases / chemistry
  • Glyceraldehyde-3-Phosphate Dehydrogenases / genetics
  • Heparin / pharmacology*
  • Hirudins / pharmacology*
  • Humans
  • Infant, Newborn
  • Plasminogen Activator Inhibitor 1 / chemistry
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Recombinant Proteins / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Umbilical Veins

Substances

  • Endotoxins
  • Fibrinolytic Agents
  • Hirudins
  • Plasminogen Activator Inhibitor 1
  • Recombinant Proteins
  • Heparin
  • Glyceraldehyde-3-Phosphate Dehydrogenases